7 completed. 7 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 7 |
| Phase 2 | 1 | Completed 1 |
Follow iloperidone: new trials by email Literature Review of iloperidone trials Research Report on iloperidone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions VHX-896 and iloperidone, Iloperidone and VHX-896 - Schizophrenia, Bipolar I Disorder | Phase 1 | Completed | Vanda Pharmaceuticals | 26 | 2024-07-11 | 2025-09-19 |
| Bioequivalence Study Between VHX-896 Tablets and Iloperidone Tablets in Healthy Volunteers VHX-896 and iloperidone, Iloperidone and VHX-896 - Healthy | Phase 1 | Completed | Vanda Pharmaceuticals | 25 | 2021-06-30 | 2022-07-11 |
| A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia Iloperidone - Schizophrenia | Phase 1 | Completed | Vanda Pharmaceuticals | 42 | 2021-01-13 | 2023-06-29 |
| Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia Iloperidone - Bipolar I Disorder, Schizophrenia | Phase 1 | Completed | Vanda Pharmaceuticals | 12 | 2019-10-07 | 2020-04-13 |
| Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients iloperidone (oral tablet) - Safety and Tolerability of Iloperidone | Phase 1 | Completed | Vanda Pharmaceuticals | 33 | 2011-10-01 | 2016-06-13 |
| Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients Iloperidone crystalline formulation, Iloperidone microparticle formulation, Oral iloperidone - Schizophrenia | Phase 1 / Phase 2 | Completed | Novartis Pharmaceuticals | 81 | 2011-04-01 | 2014-01-22 |
| Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy Volunteers Iloperidone - Hepatic Impairment | Phase 1 | Completed | Novartis Pharmaceuticals | 90 | 2010-08-01 | 2013-03-14 |
Schizophrenia (5) · Bipolar Disorder (1)
Vanda Pharmaceuticals (5) · Novartis Pharmaceuticals (2)
United States (7)